Piramal Pharma Ltd. Financials

NSE BSE

15:59 Sep 12

Piramal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

200.67

+0.51 (+0.25%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

200.67

+0.51 (+0.25%)
15:59 Sep 12

Quality

68/100
High Financial Strength

Valuation

42/100
Mid Valuation

Technical

47/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	6559.1	7081.55	8171.16	9151.18	9133.75
Operating Expenses +	5609.44	6453.31	6974.9	7706.35	7786.71
Raw Material	2396.03	2634.66	3152.6	3473.06	3553.99
Increase Decrease in Cost	55.21	68.64	-198.6	-241.41	-302.66
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1588.83	1896.35	2029.5	2307.47	2346.37
Miscellaneous Expenses	3227.51	3758.06	4342.94	5001.87	2189.01
Operating Profit	949.66	628.24	1196.26	1444.83	1347.04
Other Income	275.8	225.11	175.39	134.81	173.67
Depreciation	586.18	676.69	740.57	816.34	829.07
Interest	198.25	344.18	448.49	421.59	400.78
Profit before tax and exceptio..	441.03	-167.52	182.59	341.71	290.86
Exceptional Items	-15.08	-6.96	-62.79	0	20.74
PBT	425.95	-174.48	119.8	341.71	270.12
Provision for Taxation	109.02	66.31	161.47	323.51	282.63
Net Profit	316.93	-240.79	-41.67	18.2	28.97
NET Profit after MI	375.96	-186.46	17.82	91.13	98.07
EPS	3.19	-1.57	0.14	0.68	0.74
Operating Profit Margin (%)	14.48	8.87	14.64	15.79	14.75
Net Profit Margin (%)	5.73	-2.63	0.22	1	1.07

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	34.90	35.00	35.00	35.00	35.00
FII	30.90	31.50	31.70	31.70	31.40
MF	12.30	12.70	11.70	11.20	10.10
Others	1.90	2.10	2.40	2.60	2.90

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: